Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Malignancy Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00049556
What this trial is testing

Gefitinib in Treating Patients With Cervical Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerOvarian Cancer+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Looking for participantsNCT06923475
What this trial is testing

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Who this might be right for
Extrahepatic CholangiocarcinomaPerihilar CholangiocarcinomaDistal Cholangiocarcinoma+2 more
Amsterdam UMC, location VUmc 150
Not applicableNot Yet RecruitingNCT06375954
What this trial is testing

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Who this might be right for
Malignant Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 96
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04327986
What this trial is testing

Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CancerUnresectable or Borderline Resectable Pancreatic CancerPancreatic Neoplasms+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00039585
What this trial is testing

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT02520115
What this trial is testing

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Who this might be right for
Adnexal MassBorderline Ovarian Epithelial TumorOvarian Clear Cell Tumor+4 more
Barbara Ann Karmanos Cancer Institute 50
Testing effectiveness (Phase 2)Looking for participantsNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT00301756
What this trial is testing

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Borderline Ovarian Surface Epithelial-Stromal Tumor+5 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableUnknownNCT05791838
What this trial is testing

Experience in Borderline Ovarian Tumors

Who this might be right for
Borderline Ovarian Tumor
University of Palermo 86
Not applicableStudy completedNCT03779399
What this trial is testing

Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

Who this might be right for
Ovarian CancerBorderline Ovarian TumorsBenign Ovarian Tumor+1 more
Medical University of Lublin 60
Testing effectiveness (Phase 2)Study completedNCT00381888
What this trial is testing

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 44
Not applicableStudy completedNCT06780059
What this trial is testing

Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection

Who this might be right for
Radiotherapy, AdjuvantPhyllodes Breast TumorPrognosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 480
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Not applicableEnded earlyNCT01089374
What this trial is testing

Phyllodes Tumor Partial Breast Radiation Study

Who this might be right for
Phyllodes Tumor
Dartmouth-Hitchcock Medical Center 11
Next Page